Your browser doesn't support javascript.
loading
Is apremilast for psoriasis as effective and safe as reported in clinical trials? Five-year experience from a Greek tertiary hospital: long-term real-life efficacy and safety of apremilast in Greece.
Sotiriou, E; Tsentemeidou, A; Vakirlis, E; Sideris, N; Bakirtzi, K; Papadimitriou, I; Lallas, A; Ioannides, D.
Afiliação
  • Sotiriou E; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Tsentemeidou A; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Vakirlis E; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Sideris N; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Bakirtzi K; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Papadimitriou I; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Lallas A; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
  • Ioannides D; First Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Clin Exp Dermatol ; 46(8): 1542-1544, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33811368

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Talidomida / Anti-Inflamatórios não Esteroides / Inibidores da Fosfodiesterase 4 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Talidomida / Anti-Inflamatórios não Esteroides / Inibidores da Fosfodiesterase 4 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article